Renal safety pharmacology: Value of sensitized experimental models

Therapie

Volumn 55, Issue 1, 2000, Pages 91-96

  Idee J M ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Acute renal failure; Animal experimentation; Glomerular filtration rate; Kidney; Nephrotoxicity; Safety pharmacology

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME; HEAVY METAL; IMMUNOSUPPRESSIVE AGENT; IODINATED CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DIAGNOSTIC TEST; DRUG SAFETY; ENZYMURIA; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SODIUM EXCRETION;

ANIMALS; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL;

EID: 0343618413     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Swan SK. Aminoglycoside nephrotoxicity. Sem Nephrol 1997; 17: 27-33.
2. Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 1996; 28 (suppl. 1): S56-S62.
3. Idée JM, Beaufils H, Bonnemain B. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacology 1994; 8: 193-206.
4. Solomon R. Contrast medium-induced acute renal failure. Kidney Int 1998; 54: 230-242.
5. Andoh TF, Burdmann EA, Bennett WM. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Sem Nephrol 1997; 17: 34-45.
6. Ader JL, Rostaing L. Cyclosporin nephrotoxicity: pathophysiology and comparison with FK-506. Curr Opin Nephrol Hypert 1998; 7: 539-545.
7. Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Sem Nephrol 1997; 17: 67-76.
8. Anand AJ, Bashey B. Newer insights into cisplatin nephrotoxicity. Ann Pharmacother 1993; 27: 1519-1525.
9. Brezis M, Rosen S, Epstein FH. Acute renal failure. In: Brenner BM, Rector C, eds. The Kidney, Fourth edn. Philadelphia: WB Saunders, 1991: 993-1061.
10. Cousins MJ, Skowronski G, Plummer JL. Anaesthesia and the kidney. Anaesth Intensive Care 1983; 11: 292-320.
11. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987; 317: 150-153.
12. Fillastre JP, Baud L, Baumelou A et al. Détection de la néphrotoxicité médicamenteuse. J Pharmacol (Paris) 1986; 17 (suppl. I): 41-50.
13. Jung K. Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction. Kidney Int 1994; 46 (suppl.): S29-S33.
14. Mutti A. Detection of renal diseases in humans: developing markers and methods. Toxicol Letters 1989; 46: 177-191.
15. Bennett WM, Porter GA. Overview of clinical nephrotoxicity. In: Hook JB, Goldstein RS, eds. Toxicology of the Kidney, Second edn. New York: Raven Press, 1993: 61-97.
16. Levey AS, Madaio MP, Perrone RD. Laboratory assessment of renal disease. In: Brenner BM, Rector C, eds. The Kidney, Fourth edn. Philadelphia: WB Saunders, 1991: 919-968.
17. Estelberger W, Petek W, Zitta S et al. Determination of the glomerular filtration rate by identification of sinistrin kinetics. Eur J Clin Chem Clin Biochem 1995; 33: 201-209.
18. Davis ME, Berndt WO. Renal methods for toxicology. In: Wallace Hayes A, ed. Principles and Methods of Toxicology, Third edn. New York: Raven Press, 1994: 871-894.
19. Jobin J, Bonjour JP. Measurement of glomerular filtration rate in conscious, unrestrained rats. Am J Physiol 1985; 248: F734-F738.
20. Becker JA. Evaluation of renal function. Radiology 1991;179: 337-338.
21. Chiu PJS. Models used to assess renal function. Drugs Dev Res 1994; 32: 247-255.
22. Idée JM, Bonnemain B. Reliability of experimenal models of iodinated contrast media-induced acute renal failure. From methodological considerations to pathophysiology. Invest Radiol 1996; 31: 230-241.
23. Nakamura M, Itoh T, Miyata K et al. Difference in urinary N-acetyl-beta-D-glucosaminidase activity between male and female dogs. Renal Physiol 1983; 6: 130-133.
24. Grötsch H, Hropot M, Klaus E et al. Influences of seasonal biorhythms on urinary excretion of enzymes and other parameters. J Clin Chem Clin Biochem 1990; 28: 285-286.
25. Deray G, Dubois M, Martinez F et al. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990; 10: 507-513.
26. Harvey AM, Malvin RL. Comparison of creatinine and insulin clearances in male and female rats. Am J Physiol 1965; 209: 849-852.
27. Munger K, Baylis C. Sex differences in renal hemodynamics in rats. Am J Physiol 1988; 254: F223-F231.
28. Bennett WM, Parker RA, Elliott WC et al. Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis 1982; 145: 370-373.
29. Hackbath H, Baunack E, Winn M. Strain differences in kidney function of inbred rats, 1: Glomerular filtration rate and renal plasma flow. Lab Anim 1981; 15: 125-128.
30. Vaamonde CA, Bier RT, Papendick R et al. Acute and chronic renal effects of radiocontrast in diabetic rats: role of anesthesia and risk factors. Invest Radiol 1989; 24: 206-218.
31. Conger JD, Burke TJ. Effects of anesthetic agents on autoregulation of renal hemodynamics in the rat and dog. Am J Physiol 1976; 230: 652-657.
32. Thatte L, Vaamonde CA. Drug-induced nephrotoxicity. The crucial role of risk factors. Postgr Med 1996; 100: 83-100.
33. Brezis M. Forefront in nephrology: summary of the newer aspects of renal cell injury. Kidney Int 1992; 42: 523-539.
34. Martinez F, Deray G, Dubois M et al. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats. Anti-Cancer Drugs 1993; 4: 85-90.
35. Heyman SN, Brezis M, Reubinoff CA et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988; 82: 401-412.
36. Bertani T, Poggi A, Pozzoni R et al. Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events. Lab Invest 1982; 46: 16-23.
37. Balls M. In vitro methods in regulatory toxicology: the crucial significance of validation. Arch Toxicol Suppl 1995; 17: 155-162.